KLRF1
Basic information
Region (hg38): 12:9827481-9845007
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLRF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 3 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 3 | 0 | 0 |
Variants in KLRF1
This is a list of pathogenic ClinVar variants found in the KLRF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-9827588-A-G | not specified | Uncertain significance (Jul 26, 2021) | ||
12-9832354-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
12-9832391-C-T | not specified | Uncertain significance (Apr 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLRF1 | protein_coding | protein_coding | ENST00000279544 | 6 | 17530 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.80e-7 | 0.252 | 124646 | 0 | 15 | 124661 | 0.0000602 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.462 | 97 | 111 | 0.876 | 0.00000496 | 1529 |
Missense in Polyphen | 23 | 17.79 | 1.2928 | 241 | ||
Synonymous | -0.503 | 45 | 40.9 | 1.10 | 0.00000211 | 395 |
Loss of Function | 0.322 | 11 | 12.2 | 0.900 | 5.14e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000326 | 0.000320 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000559 | 0.0000556 |
Finnish | 0.0000466 | 0.0000464 |
European (Non-Finnish) | 0.0000367 | 0.0000353 |
Middle Eastern | 0.0000559 | 0.0000556 |
South Asian | 0.0000374 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the natural killer (NK)-mediated cytolysis of PHA-induced lymphoblasts.;
- Pathway
- Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0678
Intolerance Scores
- loftool
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 76.05
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.386
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00908
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- cell surface receptor signaling pathway;regulation of immune response
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- transmembrane signaling receptor activity;carbohydrate binding;MHC class I receptor activity